Andrew Martin

1956–2026 年に発表

244
論文数
32,926
被引用数
79
h 指数
186
i10 指数

被引用数

Andrew Martin の年別被引用数1962 年: 被引用 2 件1963 年: 被引用 2 件1964 年: 被引用 3 件1965 年: 被引用 1 件1966 年: 被引用 4 件1968 年: 被引用 3 件1970 年: 被引用 2 件1971 年: 被引用 3 件1973 年: 被引用 1 件1974 年: 被引用 1 件1975 年: 被引用 1 件1976 年: 被引用 4 件1977 年: 被引用 1 件1978 年: 被引用 1 件1979 年: 被引用 1 件1980 年: 被引用 5 件1981 年: 被引用 3 件1982 年: 被引用 1 件1983 年: 被引用 3 件1984 年: 被引用 3 件1985 年: 被引用 1 件1986 年: 被引用 1 件1987 年: 被引用 1 件1990 年: 被引用 6 件1991 年: 被引用 8 件1992 年: 被引用 7 件1993 年: 被引用 16 件1994 年: 被引用 21 件1995 年: 被引用 19 件1996 年: 被引用 19 件1997 年: 被引用 24 件1998 年: 被引用 22 件1999 年: 被引用 23 件2000 年: 被引用 44 件2001 年: 被引用 48 件2002 年: 被引用 44 件2003 年: 被引用 66 件2004 年: 被引用 68 件2005 年: 被引用 86 件2006 年: 被引用 136 件2007 年: 被引用 147 件2008 年: 被引用 143 件2009 年: 被引用 168 件2010 年: 被引用 169 件2011 年: 被引用 206 件2012 年: 被引用 203 件2013 年: 被引用 202 件2014 年: 被引用 210 件2015 年: 被引用 192 件2016 年: 被引用 170 件2017 年: 被引用 203 件2018 年: 被引用 212 件2019 年: 被引用 547 件2020 年: 被引用 696 件2021 年: 被引用 834 件2022 年: 被引用 679 件2023 年: 被引用 630 件2024 年: 被引用 996 件2025 年: 被引用 531 件2026 年: 被引用 29 件1967 年は被引用が無いため表示していません1969 年は被引用が無いため表示していません1972 年は被引用が無いため表示していません1988〜1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,807 件、この内訳の 22%イギリス: 引用元論文 1,085 件、この内訳の 8.5%ドイツ: 引用元論文 861 件、この内訳の 6.7%中国: 引用元論文 856 件、この内訳の 6.7%オーストラリア: 引用元論文 596 件、この内訳の 4.7%カナダ: 引用元論文 518 件、この内訳の 4.1%フランス: 引用元論文 479 件、この内訳の 3.8%イタリア: 引用元論文 463 件、この内訳の 3.6%オランダ: 引用元論文 321 件、この内訳の 2.5%日本: 引用元論文 318 件、この内訳の 2.5%インド: 引用元論文 297 件、この内訳の 2.3%スペイン: 引用元論文 282 件、この内訳の 2.2%
0%22%その他 30.4%

分野

  • Medicine39.2%
  • Biochemistry, Genetics and Molecular Biology13%
  • Computer Science8.6%
  • Engineering7.5%
  • Materials Science5.3%
  • Neuroscience5%
  • その他21.4%

トピック

  • Prostate Cancer Treatment and Research4.3%
  • Radiopharmaceutical Chemistry and Applications2.6%
  • Prostate Cancer Diagnosis and Treatment2.3%
  • Advanced Cellulose Research Studies1.9%
  • Biofuel production and bioconversion1.7%
  • Sepsis Diagnosis and Treatment1.4%
  • その他85.8%

共著者

全論文

検索で開く
  1. [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Martin, Ian D. Davis, Arun Azad, Wei Chua, Ian D. Davis, Nattakorn Dhiantravan, Louise Emmett, Kate Ford, Michael S. Hofman, Roslyn J. Francis, Craig Gedye, Jeffrey C. Goh, Alex Guminski, Edward Hsiao, Amir Iravani, Anthony M. Joshua, Ian Kirkwood, Ailsa Langford, Nicola Jane Lawrence, Sze-Ting Lee, Peter Lin, Andrew Martin, William M. McDonald, Margaret McJannett, Siobhan Ng, David A. Pattison, Shakher Ramdave, Nisha Rana, Andrew Redfern, Natalie Rutherford, Shahneen Sandhu, Andrew M. Scott, Martin R. Stockler, Shalini Subramaniam, Thean Hsiang Tan, John Violet, Andrew Weickhardt, Scott Williams, Sonia Yip, Alison Y. Zhang - The Lancet 2021 被引用: 1,082

  2. Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Zielinski, Christopher J. Sweeney - New England Journal of Medicine 2019 被引用: 1,593

  3. An Empirical Method for Estimating the Degree of Crystallinity of Native Cellulose Using the X-Ray Diffractometer

    著者: , , , - Textile Research Journal 1959 被引用: 8,472

  4. PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey C. Goh, Alex Guminski, Anis Hamid, Mohammad B. Haskali, Rodney J. Hicks, Edward Hsiao, Amir Iravani, Anthony M. Joshua, Ian Kirkwood, Grace Kong, Edmond M. Kwan, Ailsa Langford, Nicola Jane Lawrence, Sze-Ting Lee, Jeremy Lewin, Peter Lin, Andrew Martin, William M. McDonald, Margaret McJannett, Kate Moodie, Declan G. Murphy, Siobhan Ng, David A. Pattison, Izabella Pokorski, Shakher Ramdave, Aravind S. Ravi Kumar, Andrew Redfern, Natalie Rutherford, Javad Saghebi, Shahneen Sandhu, Andrew M. Scott, Lavinia Spain, Martin R. Stockler, Shalini Subramaniam, Thean Hsiang Tan, Sue Ping Thang, Ben Tran, Roslyn E. Wallace, Andrew Weickhardt, Scott Williams, Sonia Yip, Alison Y. Zhang, Sonia Yip, Alison Y. Zhang - The Lancet Oncology 2022 被引用: 266

  5. Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian D. Davis, Tim Akhurst, Ramin Alipour, Dale L. Bailey, Patricia Banks, Alexis Beaulieu, Louise Campbell, Megan Crumbaker, Nattakorn Dhiantravan, Anis Hamid, Mohammad B. Haskali, Terry Hung, Grace Kong, Nick Lawrence, Jeremy Lewin, Michael McCarthy, Kate Moodie, Declan G. Murphy, Andrew Nguyen, David Pook, Aravind Ravi Kumar, Paul Roach, Peter Roselt, Javad Saghebi, Geoffrey Schembri, Lavinia Spain, Shalini Subramaniam, Sue Ping Thang, Paul Thomas, Ben Tran, Roslyn E. Wallace, Sonia Yip - The Lancet Oncology 2023 被引用: 199

  6. Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian D. Davis, Ehtesham Abdi, Suzanne Allan, Patricia Bastick, Stephen Begbie, Robert Blum, Karen Briscoe, Daniel Brungs, Sean Bydder, Bala Renuka Chittajallu, Michelle R. Cronk, Katharine Cuff, Ian D. Davis, Anthony Dowling, Mark Frydenberg, M. C. George, Lisa G. Horvath, Elizabeth Hovey, Anthony M. Joshua, Narayan Karanth, Ganessan Kichenadasse, Laurence E. Krieger, Gavin Marx, Maitham Mathlum, Louise Nott, Zulfiquer Otty, Francis Parnis, David Pook, Shahneen Sandhu, Sanjeev Sewak, Amanda Gwendolyn Stevanovic, Martin R. Stockler, Aneta Suder, Hsiang Tan, Javier Torres, Simon Troon, Craig Underhill, Andrew Weickhardt, Robert Zielinski, Tahir Abbas, Ghadeer Anan, Chris Booth, H. E. A. Campbell, Kim Chi, Joseph L. Chin, E. Chouinard, Bryan Donnelly, Darrel Drachenberg, Amir Faghih, Antonio Finelli, Sebastién J. Hotte, Krista Noonan, Scott North, Mohammad Rassouli, Neil Reaume, Ricardo Rendon, Fred Saad, Evgeny Sadikov, Éric Vigneault, Paweł Zalewski, John McCaffrey, Ray McDermott, Patrick G. Morris, Miriam O’Connor, Paul Donnellan, Dearbhaile M. O’Donnell, Dearbhaile O'Donnell, Peter C.C. Fong, Alvin Tan, Simon Chowdhury ほか 13 名 - The Lancet Oncology 2023 被引用: 188

  7. Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease

    著者: , , , , , , , , , , , , , - Nature Communications 2023 被引用: 124

  8. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention

    著者: , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 628

  9. [177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alison Yan Zhang, Sonia Yip, Hayley Thomas, Ailsa Langford, Michael S. Hofman, Margaret McJannett, Andrew Martin, Martin R. Stockler, Ian D. Davis - The Lancet Oncology 2024 被引用: 155

  10. Addition of a photocrosslinking amino acid to the genetic code of Escherichia coli

    著者: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2002 被引用: 735

  11. Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Uwe Kordes, David E. Kram, Matija Snuderl, Leslie Bridges, Andrew Martin, Lawrence J. Doey, Safa Al‐Sarraj, Christopher Chandler, Bassel Zebian, Claire Cairns, Rachael Natrajan, Jessica K.R. Boult, Simon P. Robinson, Martin Sill, Ira J. Dunkel, Stephen W. Gilheeney, Marc K. Rosenblum, Debbie Hughes, Paula Proszek, Tobey J. MacDonald, Matthias Preusser, Christine Haberler, Irene Slavc, Roger J. Packer, Ho‐Keung Ng, Shani Caspi, Mara Popović, Barbara Faganel Kotnik, Matthew D. Wood, Lissa Baird, Monika A. Davare, David A. Solomon, Thale Kristin Olsen, Petter Brandal, Michael Farrell, Jane Cryan, Michael Capra, Michael Karremann, Jens Schittenhelm, Martin U. Schuhmann, Martin Ebinger, Winand N.M. Dinjens, Kornelius Kerl, Simone Hettmer, Torsten Pietsch, Felipe Andreiuolo, Pablo Hernáiz Driever, Andrey Korshunov, Lotte Hiddingh, Barbara C. Worst, Dominik Sturm, Marc Zuckermann, Olaf Witt, Tabitha Bloom, Clare Mitchell, Evelina Miele, Giovanna Stefania Colafati, Francesca Diomedi‐Camassei, Simon Bailey, Andrew S. Moore, Tim Hassall, Stephen P. Lowis, Maria Tsoli, Mark J. Cowley, David S. Ziegler, Matthias A. Karajannis, Kristian Aquilina, Darren Hargrave, Fernando Carceller, Lynley V. Marshall ほか 14 名 - Cancer Discovery 2020 被引用: 278

  12. Estimated Burden of Community-Onset Respiratory Syncytial Virus–Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014–15

    著者: , , , , , , , , , , , , , , , , - Journal of the Pediatric Infectious Diseases Society 2019 被引用: 128

  13. Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications

    著者: , , , , , - Bioconjugate Chemistry 2019 被引用: 228

  14. Evaluation of177Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective177Lu-PSMA-617 and NOX66 Combination Trial (LuPIN)

    著者: , , , , , , , , , , , , , , - Journal of Nuclear Medicine 2022 被引用: 60

  15. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Harrison A. Edwards, Nicholas De Rosa, T. D. Stewart, Brent J. Doolan, Yonatan Kok, Kate Simpson, Zhi M. Low, Tom Kovitwanichkanont, Richard A. Scolyer, Haryana M. Dhillon, Janette L. Vardy, Steven J. Chadban, David G. Bowen, Andrew C. Chen, Diona L. Damian - New England Journal of Medicine 2023 被引用: 99

  16. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - EP Europace 2018 被引用: 392

  17. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003*

    著者: , , , - Critical Care Medicine 2007 被引用: 1,250

  18. TheraP: a randomized phase 2 trial of 177 Lu‐ PSMA ‐617 theranostic treatment vs cabazitaxel in progressive metastatic castration‐resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)

    著者: , , , , , , , , , , , , , - British Journal of Urology 2019 被引用: 162

  19. A checklist for assessing the methodological quality of concurrent tES-fMRI studies (ContES checklist): a consensus study and statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Iman Ghodratitoostani, Gadi Gilam, Roland H. Grabner, Joel D. Greenspan, Georg Groen, Gesa Hartwigsen, Tobias U. Hauser, Christoph S. Herrmann, Chi‐Hung Juan, Bart Krekelberg, Stéphanie Lefebvre, Sook‐Lei Liew, Kristoffer H. Madsen, Rasoul Khayati, Nastaran Malmir, Paola Marangolo, Andrew Martin, Timothy J. Meeker, Hossein Mohaddes Ardabili, Marius Moisa, Davide Momi, Beni Mulyana, Alexander Opitz, Natasza Orlov, Patrick Ragert, Christian C. Ruff, Giulio Ruffini, Michaela Ruttorf, Arshiya Sangchooli, Klaus Schellhorn, Gottfried Schlaug, Bernhard Sehm, Ghazaleh Soleimani, Hosna Tavakoli, Benjamin Thompson, Dagmar Timmann, Aki Tsuchiyagaito, Ulrich Martin, Johannes Vosskuhl, Christiane Anne Weinrich, Mehran Zare-Bidoky, Xiaochu Zhang, Benedikt Zoefel, Michael A. Nitsche, Marom Bikson - Nature Protocols 2022 被引用: 56

  20. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL

    著者: , , , , , - Quality of Life Research 1999 被引用: 671

  21. Efficient and Provably Secure Key Agreement for Modern Smart Metering Communications

    著者: , , - Energies 2018 被引用: 67

  22. Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alison Y. Zhang, Robert Zielinski, Christopher J. Sweeney, for the ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) - Journal of Clinical Oncology 2021 被引用: 60

  23. 177Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN): Patient Outcomes and Predictors of Treatment Response in a Phase I/II Trial

    著者: , , , , , , , , , , , , , - Journal of Nuclear Medicine 2021 被引用: 48

  24. Ontogeny of orientation flight in the honeybee revealed by harmonic radar

    著者: , , , , , , , , , , - Nature 2000 被引用: 332